153 related articles for article (PubMed ID: 31639056)
21. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.
Chen YQ; Shi HZ; Qin XJ; Mo WN; Liang XD; Huang ZX; Yang HB; Wu C
Am J Respir Crit Care Med; 2005 Dec; 172(11):1434-9. PubMed ID: 16151041
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
23. The Quantitative and Functional Changes of Postoperative Peripheral Blood Immune Cell Subsets Relate to Prognosis of Patients with Subarachnoid Hemorrhage: A Preliminary Study.
Zhou Y; Jiang Y; Peng Y; Zhang M
World Neurosurg; 2017 Dec; 108():206-215. PubMed ID: 28866066
[TBL] [Abstract][Full Text] [Related]
24. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract][Full Text] [Related]
25. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
26. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
[TBL] [Abstract][Full Text] [Related]
27. Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells in vitro.
Hou M; Zhou NB; Li H; Wang BS; Wang XQ; Wang XW; Wang KG; Xue FS
J Surg Res; 2016 Jun; 203(2):306-12. PubMed ID: 27363637
[TBL] [Abstract][Full Text] [Related]
28. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
[TBL] [Abstract][Full Text] [Related]
29. Frequencies of PD-1- and PD-L1- positive T CD3
Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
[TBL] [Abstract][Full Text] [Related]
30. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses.
Hegmans JP; Hemmes A; Hammad H; Boon L; Hoogsteden HC; Lambrecht BN
Eur Respir J; 2006 Jun; 27(6):1086-95. PubMed ID: 16540497
[TBL] [Abstract][Full Text] [Related]
31. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor.
Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ
Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease.
Budna J; Spychalski Ł; Kaczmarek M; Frydrychowicz M; Goździk-Spychalska J; Batura-Gabryel H; Sikora J
Immunobiology; 2017 Mar; 222(3):499-505. PubMed ID: 27773662
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
35. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
[TBL] [Abstract][Full Text] [Related]
36. Immunoregulatory function of HLA-G in gastric cancer.
Tuncel T; Karagoz B; Haholu A; Ozgun A; Emirzeoglu L; Bilgi O; Kandemir EG
Asian Pac J Cancer Prev; 2013; 14(12):7681-4. PubMed ID: 24460353
[TBL] [Abstract][Full Text] [Related]
37. Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection.
Petitjean G; Chevalier MF; Tibaoui F; Didier C; Manea ME; Liovat AS; Campa P; Müller-Trutwin M; Girard PM; Meyer L; Barré-Sinoussi F; Scott-Algara D; Weiss L
AIDS; 2012 Jan; 26(2):139-48. PubMed ID: 22045342
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions.
Budna J; Kaczmarek M; Kolecka-Bednarczyk A; Spychalski Ł; Zawierucha P; Goździk-Spychalska J; Nowicki M; Batura-Gabryel H; Sikora J
J Immunol Res; 2018; 2018():9876014. PubMed ID: 29785404
[TBL] [Abstract][Full Text] [Related]
39. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.
Yazdani M; Khosropanah S; Hosseini A; Doroudchi M
Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237
[TBL] [Abstract][Full Text] [Related]
40. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]